Bausch Health Companies (BHC) Stock Statistics & Valuation Metrics

Bausch Health Companies has a market cap or net worth of $2.51B. The enterprise value is $22.47B.

Bausch Health Companies has 369,550,080 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bausch Health Companies’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -2.97%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Bausch Health Companies had revenue of 9.63B and earned -46.00M in profits. Earnings per share was -0.12.

In the last 12 months, operating cash flow was 1.60B and capital expenditures -381.00M, giving a free cash flow of 1.22B billion.

Bausch Health Companies pays an annual dividend of $1, resulting in a dividend yield of ―

Bausch Health Companies upcoming earnings date is Oct 30, 2025, Before Open (Confirmed).

Bausch Health Companies as a current ratio of 0.86, with Debt / Equity ratio of -3000.87%

In the past 12 months, Bausch Health Companies has paid 239.00M in taxes.

Bausch Health Companies EV to EBITDA ratio is 8.29, with an EV/FCF ratio of 18.62.

Bausch Health Companies has $1.13B in cash and marketable securities with $21.51B in debt, giving a net cash position of $20.38B billion.

Gross margin is 70.90%, with operating margin of 16.06%, and net profit margin of -0.48%.

The average price target for Bausch Health Companies is $8.33, which is 11.43% higher than the current price. The consensus rating is Hold